|
RHÖN-KLINIKUM Aktiengesellschaft
28.05.2020 / 16:00
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
|
Name:
|
RHÖN-KLINIKUM Aktiengesellschaft
|
|
Street:
|
Salzburger Leite 1
|
|
Postal code:
|
97616
|
|
City:
|
Bad Neustadt a.d.Saale
Germany
|
|
Legal Entity Identifier (LEI):
|
529900MVGMIVUDQY9E20
|
2. Reason for notification
|
X
|
Acquisition/disposal of shares with voting rights
|
|
|
Acquisition/disposal of instruments
|
|
|
Change of breakdown of voting rights
|
|
|
Other reason:
|
3. Details of person subject to the notification obligation
Natural person (first name, surname):
Eugen
Münch
Date of birth:
27 Feb 1945
|
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached:
6. Total positions
|
|
% of voting rights attached to shares
(total of 7.a.)
|
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
|
Total of both in %
(7.a. + 7.b.)
|
Total number of voting rights pursuant to Sec. 41 WpHG
|
|
New
|
45.80 %
|
0 %
|
45.80 %
|
66962470
|
|
Previous notification
|
14.56 %
|
0 %
|
14.56 %
|
/
|
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
|
ISIN
|
Absolute
|
In %
|
|
|
Direct
(Sec. 33 WpHG)
|
Indirect
(Sec. 34 WpHG)
|
Direct
(Sec. 33 WpHG)
|
Indirect
(Sec. 34 WpHG)
|
|
DE0007042301
|
2469971
|
28196089
|
3.69 %
|
42.11 %
|
|
Total
|
30666060
|
45.80 %
|
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
|
Type of instrument
|
Expiration or maturity date
|
Exercise or conversion period
|
Voting rights absolute
|
Voting rights in %
|
|
|
|
|
|
%
|
|
|
|
Total
|
|
%
|
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
|
Type of instrument
|
Expiration or maturity date
|
Exercise or conversion period
|
Cash or physical settlement
|
Voting rights absolute
|
Voting rights in %
|
|
|
|
|
|
|
%
|
|
|
|
|
Total
|
|
%
|
8. Information in relation to the person subject to the notification obligation
|
|
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
|
|
X
|
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
|
|
Name
|
% of voting rights (if at least 3% or more)
|
% of voting rights through instruments (if at least 5% or more)
|
Total of both (if at least 5% or more)
|
|
Eugen Münch
|
3.69 %
|
%
|
%
|
|
HCM SE
|
42.11 %
|
%
|
42.11 %
|
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
|
Proportion of voting rights
|
Proportion of instruments
|
Total of both
|
|
%
|
%
|
%
|
10. Other explanatory remarks:
|
On 28.2.2020, Asklepios Kliniken GmbH & Co. KGaA (“AK”) concluded a purchase agreement (“PA”) with Eugen Münch (“EM”) and Ingeborg Münch (“IM”) regarding the acquisition of a 12.39% shareholding in RHÖN-KLINIKUM AG (“RHK”), subject to a condition precedent. Concerning one part of the transaction (5.81%), the condition has been met on 26.5.2020. According to a joint venture agreement dated 28.2.2020 (“JV Agreement”), AK has undertaken, subject to a condition precedent, to contribute AK’s direct shareholding, existing after the partial completion of the PA, in RHK (34.49%) into AMR Holding GmbH (“AMR”), which took place on 26.5.2020. According to the JV Agreement, HCM SE has undertaken, subject to a condition precedent, to contribute its 7.61% shareholding in RHK into AMR, which was completed on 26.5.2020. Following the partial completion of the PA and the contributions, AMR holds 42.11% of the voting shares in RHK. HCM SE and AK coordinate their behavior with regard to these shares.
|
Date
28.05.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|